Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases
V. Reymann
(1, 2)
,
D. Bessis
(1, 2, 3)
,
B. Bergeret
(4)
,
D. Lipsker
(5)
,
A. Du-Thanh
(1, 2, 3)
,
N. Terrail
(1)
,
M. Dandurand
(4)
,
O. Dereure
(1, 2, 3)
1
CHRU Montpellier -
Centre Hospitalier Régional Universitaire [Montpellier]
2 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
3 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
4 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes
5 CHU Strasbourg - Centre Hospitalier Universitaire [Strasbourg]
2 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
3 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
4 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes
5 CHU Strasbourg - Centre Hospitalier Universitaire [Strasbourg]
D. Lipsker
- Fonction : Auteur
- PersonId : 765615
- ORCID : 0000-0003-4675-0336
- IdRef : 063760371
O. Dereure
- Fonction : co dernier-auteur
- PersonId : 759260
- ORCID : 0000-0001-8736-1922